Benign Essential Blepharospasm Research Foundation

🚨 NEW BEBRF VIDEO AVAILABLE🚨

What if one of the biggest barriers to better treatments for blepharospasm and dystonia isn’t the treatment itself—but how we measure whether it works?

Outcome Measures for Research
David A. Peterson, PhD
2025 Program Director, BEBRF Annual Symposium
Associate Research Scientist, UC San Diego Institute for Neural Computation; Director, Computational Neurology Center (UC San Diego)

Dr. Peterson’s work focuses on computational neuroscience and machine learning approaches to movement disorders, with an emphasis on improving how blepharospasm and dystonia are objectively measured in research and clinical care.

This presentation explores how outcomes are currently measured in clinical studies - and why that process plays a critical role in how new treatments are evaluated and developed.

Topics include:
• Clinical rating scales used in trials
• Patient-reported outcome measures
• Emerging tools such as video analysis, EMG, and digital approaches

At the core is a simple idea: better measurement leads to better science - and ultimately better treatments.

🎥 Watch here:
👉 https://youtu.be/s5VgdLBKj08

Outcome Measures for Research - David Peterson, Phd Outcome Measures for Research: David Peterson, Phd presenting live from 2025 BEBRF Annual Symposium at Sheraton Mission Vailley San Diego, San Diego, CA, US...